1. 028 Efficacy and Pharmacokinetics of Oral Testosterone (LPCN 1021) in Hypogonadal Men. (1st May 2016) Authors: Chidambaram, N.; Goldstein, I.; Dobs, A.S.; Kaminetsky, J.C.; Miner, M.M.; Khera, M.; Delconte, A.; Chidambaram, N.; Nachaegari, S.; Patel, M.; Wang, C. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 030 Dose Titration and Safety of Oral Testosterone in Hypogonadal Men: Results from the SOAR Study. (1st May 2016) Authors: Khera, M.; Dobs, A.S.; Wang, C.; Kaminetsky, J.C.; Goldstein, I.; Delconte, A.; Chidambaram, N.; Patel, M.V.; Nachaegari, S.; Miner, M.M. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 1 Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 036 Assessment of Fasting and Varying Meal Fat Content on the Bioavailability of Oral Testosterone Undecanoate (LPCN 1021) in Hypogonadal Men. (1st May 2016) Authors: Khera, M.; Dobs, A.S.; Miner, M.M.; Wang, C.; Delconte, A.; Chidambaram, N.; Nachaegari, S.; Patel, M. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗